Organization
Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY
1 abstract
Abstract
Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update.Org: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, Washington University, St. Louis, MO, Hematology Department, University Hospital of Leon, Leon, Spain, Catholic University of Leuven, Leuven, Belgium,